Duodenum-preserving pancreatic head resection shows promising outcomes for patients with benign and premalignant neoplasms.

• 90-day mortality is only 0.47% across 1063 patients.
• Recurrence rates are low: 5.61% for intraductal papillary mucinous neoplasms, with no recurrences noted among those treated for micro-carcinoma.

Consider this technique for appropriate patients to enhance surgical management of pancreatic head neoplasms.

• Disease-specific survival rates stand at 99.3% at 2 years and 97.3% at 5 years.